Exodus Point Capital Management, LP Mimedx Group, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.16 - $8.08 $1.09 Million - $1.42 Million	176,351 New	176,351 $1.22 Million
Q2 2023 Aug 10, 2023	BUY	$3.14 - $6.61 $289,533 - $609,494	92,208 New	92,208 $609,000
Q1 2022 May 13, 2022	SELL	$4.27 - $6.27 $138,463 - $203,317	-32,427 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$5.7 - $8.48 $2,861 - $4,256	502 Added 1.57%	32,427 $196,000
Q3 2021 Nov 15, 2021	BUY	$5.52 - $15.83 $176,226 - $505,372	31,925 New	31,925 $193,000
Q2 2021 Aug 16, 2021	SELL	$9.02 - $12.72 $3.88 Million - $5.47 Million	-430,142 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$8.48 - $11.28 $608,228 - $809,058	71,725 Added 20.01%	430,142 $4.43 Million
Q4 2020 Feb 16, 2021	BUY	$5.32 - $10.17 $1.91 Million - $3.65 Million	358,417 New	358,417 $3.25 Million

208

98.1M

65.3K

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.08B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.